AADI Aadi Bioscience Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: AADI

Price (delayed)

$1.68

Market cap

$41.25M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.44

Enterprise value

-$20.37M

Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing compounds that activate Tie2 for indications in which the Company believes that activation of Tie2 may have therapeutic potential. The ...

Highlights
Aadi Bioscience's revenue has soared by 60% YoY and by 4.7% from the previous quarter
The company's gross profit has surged by 55% YoY
The company's EPS rose by 9% YoY but it fell by 5% QoQ
AADI's quick ratio has dropped by 53% year-on-year and by 29% since the previous quarter
The company's equity fell by 34% YoY and by 11% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.aerpio.com
Peers: OPTN OPK ORGO

Key stats

What are the main financial stats of AADI
Market
Shares outstanding
24.55M
Market cap
$41.25M
Enterprise value
-$20.37M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.39
Price to sales (P/S)
1.86
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.84
Earnings
Revenue
$24.35M
EBIT
-$65.53M
EBITDA
-$64.9M
Free cash flow
-$63.64M
Per share
EPS
-$2.44
Free cash flow per share
-$2.36
Book value per share
$4.29
Revenue per share
$0.9
TBVPS
$4.92
Balance sheet
Total assets
$132.42M
Total liabilities
$27.23M
Debt
$1.27M
Equity
$105.2M
Working capital
$98.19M
Liquidity
Debt to equity
0.01
Current ratio
4.72
Quick ratio
4.33
Net debt/EBITDA
0.95
Margins
EBITDA margin
-266.5%
Gross margin
88.5%
Net margin
-270%
Operating margin
-295.4%
Efficiency
Return on assets
-44.3%
Return on equity
-52.5%
Return on invested capital
-91%
Return on capital employed
-61.8%
Return on sales
-269.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AADI stock price

How has the Aadi Bioscience stock price performed over time
Intraday
-5.62%
1 week
-6.67%
1 month
-22.58%
1 year
-79%
YTD
-16.83%
QTD
-28.21%

Financial performance

How have Aadi Bioscience's revenue and profit performed over time
Revenue
$24.35M
Gross profit
$21.55M
Operating income
-$71.93M
Net income
-$65.77M
Gross margin
88.5%
Net margin
-270%
Aadi Bioscience's revenue has soared by 60% YoY and by 4.7% from the previous quarter
The company's gross profit has surged by 55% YoY
The net margin has grown by 32% YoY
The operating margin rose by 28% YoY

Growth

What is Aadi Bioscience's growth rate over time

Valuation

What is Aadi Bioscience stock price valuation
P/E
N/A
P/B
0.39
P/S
1.86
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.84
The company's EPS rose by 9% YoY but it fell by 5% QoQ
AADI's price to book (P/B) is 74% less than its 5-year quarterly average of 1.5 and 61% less than its last 4 quarters average of 1.0
The company's equity fell by 34% YoY and by 11% QoQ
The price to sales (P/S) is 100% less than the 5-year quarterly average of 783.5 and 72% less than the last 4 quarters average of 6.7
Aadi Bioscience's revenue has soared by 60% YoY and by 4.7% from the previous quarter

Efficiency

How efficient is Aadi Bioscience business performance
The return on invested capital is up by 37% year-on-year but it has declined by 34% since the previous quarter
The company's return on sales rose by 32% YoY
The company's return on equity fell by 22% YoY and by 15% QoQ
The return on assets has declined by 19% year-on-year and by 13% since the previous quarter

Dividends

What is AADI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AADI.

Financial health

How did Aadi Bioscience financials performed over time
AADI's quick ratio has dropped by 53% year-on-year and by 29% since the previous quarter
AADI's current ratio has shrunk by 51% YoY and by 27% QoQ
The debt is 99% less than the equity
The company's equity fell by 34% YoY and by 11% QoQ
The debt has contracted by 24% YoY and by 7% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.